• Company
    • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • CAREERS
    • CONTACT US
  • Patients
    • OSTEOPOROSIS OVERVIEW
    • VCF OVERVIEW
    • RISK FACTORS
    • VCF SYMPTOMS
    • TREATMENT OPTIONS
  • Professionals
    • TREATMENT OPTIONS
    • CLINICAL EXPERIENCE
    • PROCEDURE
  • Product
    • BLAZER
    • KIVA VCF TREATMENT SYSTEM
    • VERTEBRAL AUGMENTATION CEMENT KIT
  • News & Events
    • NEWS
    • EVENTS
  • HOME
  • CONTACT US

News

January 7, 2008
Benvenue Medical Closes $15 Million Series B Financing February

February 23, 2009
Benvenue Medical Receives CE Mark Approval for Kiva™ VCF Treatment System

August 12, 2010
Benvenue Medical Announces First Clinical Use of Blazer - a Novel System for Vertebral Augmentation Procedures

August 19, 2010
Benvenue  Medical Begins Enrollment in Landmark Study versus Balloon Kyphoplasty 

April 11, 2011
Benvenue Medical Closes $35.5M Series C Financing

July 19, 2011
Benvenue Medical Adds Two Senior Executives in Sales and Marketing

October 20, 2011
Zimmer Spine and Benvenue Medical Enter Exclusive Distribution Agreement for Kiva® VCF Treatment System

March 20, 2012
Benvenue Medical Starts Enrolling Patients in the Post-Market LIFT Study on the Luna Interbody System for Degenerative Disc Disease 

March 26, 2012
Benvenue Medical Announces US Launch of the Blazer™ Vertebral Augmentation System 

March 27, 2012
Benvenue Medical Enrolls 250th Patient in KAST Evaluating Kiva for Vertebral Compression Fractures 

May 21, 2012
Device Industry Veterans Join Benvenue Medical Board of Directors 

June 28, 2012
Benvenue Medical Secures $25 Million Series D Financing

  • Legal
  • Site Map

©2010-2013 Benvenue Medical, Inc. All rights reserved. ML1700.M